PRO-DEX INC (PDEX) Stock Fundamental Analysis
NASDAQ:PDEX - Nasdaq - US74265M2052 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to PDEX. PDEX was compared to 191 industry peers in the Health Care Equipment & Supplies industry. PDEX gets an excellent profitability rating and is at the same time showing great financial health properties. PDEX is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make PDEX a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year PDEX was profitable.
PDEX had a positive operating cash flow in the past year.
In the past 5 years PDEX has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: PDEX reported negative operating cash flow in multiple years.
1.2 Ratios
PDEX's Return On Assets of 11.18% is amongst the best of the industry. PDEX outperforms 93.19% of its industry peers.
PDEX's Return On Equity of 21.21% is amongst the best of the industry. PDEX outperforms 94.24% of its industry peers.
PDEX has a Return On Invested Capital of 18.51%. This is amongst the best in the industry. PDEX outperforms 97.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PDEX is above the industry average of 7.68%.
The last Return On Invested Capital (18.51%) for PDEX is above the 3 year average (11.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 21.21% | ||
| ROIC | 18.51% |
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
1.3 Margins
The Profit Margin of PDEX (11.06%) is better than 86.91% of its industry peers.
PDEX's Profit Margin has declined in the last couple of years.
PDEX has a Operating Margin of 16.83%. This is amongst the best in the industry. PDEX outperforms 89.53% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
PDEX has a Gross Margin of 30.02%. This is in the lower half of the industry: PDEX underperforms 75.39% of its industry peers.
PDEX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.83% | ||
| PM (TTM) | 11.06% | ||
| GM | 30.02% |
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PDEX is creating value.
Compared to 1 year ago, PDEX has less shares outstanding
PDEX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PDEX has an improved debt to assets ratio.
2.2 Solvency
PDEX has an Altman-Z score of 7.01. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.01, PDEX belongs to the best of the industry, outperforming 86.91% of the companies in the same industry.
The Debt to FCF ratio of PDEX is 10.01, which is on the high side as it means it would take PDEX, 10.01 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 10.01, PDEX is doing good in the industry, outperforming 73.82% of the companies in the same industry.
PDEX has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
PDEX has a Debt to Equity ratio (0.33) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 10.01 | ||
| Altman-Z | 7.01 |
ROIC/WACC2.06
WACC8.97%
2.3 Liquidity
PDEX has a Current Ratio of 2.58. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX has a Current ratio (2.58) which is in line with its industry peers.
PDEX has a Quick Ratio of 1.44. This is a normal value and indicates that PDEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.44, PDEX is not doing good in the industry: 61.78% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 168.00% over the past year.
The Earnings Per Share has been decreasing by -6.76% on average over the past years.
The Revenue has grown by 26.44% in the past year. This is a very strong growth!
Measured over the past years, PDEX shows a quite strong growth in Revenue. The Revenue has been growing by 14.66% on average per year.
EPS 1Y (TTM)168%
EPS 3Y-17.89%
EPS 5Y-6.76%
EPS Q2Q%335.71%
Revenue 1Y (TTM)26.44%
Revenue growth 3Y12.29%
Revenue growth 5Y14.66%
Sales Q2Q%33.4%
3.2 Future
PDEX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 97.88% yearly.
Based on estimates for the next years, PDEX will show a quite strong growth in Revenue. The Revenue will grow by 19.04% on average per year.
EPS Next Y278.39%
EPS Next 2Y97.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year37.45%
Revenue Next 2Y19.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.01 indicates a quite expensive valuation of PDEX.
73.82% of the companies in the same industry are more expensive than PDEX, based on the Price/Earnings ratio.
PDEX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.63, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 24.02, PDEX is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PDEX is valued a bit cheaper than the industry average as 75.92% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.85, PDEX is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.01 | ||
| Fwd PE | 24.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PDEX is valued a bit cheaper than 77.49% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PDEX is valued a bit cheaper than the industry average as 69.63% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 116.12 | ||
| EV/EBITDA | 17.89 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PDEX may justify a higher PE ratio.
A more expensive valuation may be justified as PDEX's earnings are expected to grow with 97.88% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y97.88%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PDEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PDEX (4/21/2025, 8:00:00 PM)
58.31
-2.52 (-4.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners31.57%
Inst Owner Change-0.01%
Ins Owners36.12%
Ins Owner Change2.38%
Market Cap190.09M
Analysts82.86
Price Target55.08 (-5.54%)
Short Float %0.81%
Short Ratio0.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.46%
Min EPS beat(2)57.38%
Max EPS beat(2)153.55%
EPS beat(4)3
Avg EPS beat(4)48.25%
Min EPS beat(4)-46.78%
Max EPS beat(4)153.55%
EPS beat(8)5
Avg EPS beat(8)5.08%
EPS beat(12)6
Avg EPS beat(12)4.21%
EPS beat(16)7
Avg EPS beat(16)8.33%
Revenue beat(2)2
Avg Revenue beat(2)19.98%
Min Revenue beat(2)19.3%
Max Revenue beat(2)20.66%
Revenue beat(4)4
Avg Revenue beat(4)21.27%
Min Revenue beat(4)6.16%
Max Revenue beat(4)38.97%
Revenue beat(8)7
Avg Revenue beat(8)14.81%
Revenue beat(12)10
Avg Revenue beat(12)12.67%
Revenue beat(16)13
Avg Revenue beat(16)13.18%
PT rev (1m)0%
PT rev (3m)3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.3%
EPS NY rev (1m)15%
EPS NY rev (3m)15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.01 | ||
| Fwd PE | 24.02 | ||
| P/S | 3.12 | ||
| P/FCF | 116.12 | ||
| P/OCF | 67.08 | ||
| P/B | 5.97 | ||
| P/tB | 5.98 | ||
| EV/EBITDA | 17.89 |
EPS(TTM)2.01
EY3.45%
EPS(NY)2.43
Fwd EY4.16%
FCF(TTM)0.5
FCFY0.86%
OCF(TTM)0.87
OCFY1.49%
SpS18.71
BVpS9.76
TBVpS9.75
PEG (NY)0.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 21.21% | ||
| ROCE | 23.75% | ||
| ROIC | 18.51% | ||
| ROICexc | 20.78% | ||
| ROICexgc | 20.8% | ||
| OM | 16.83% | ||
| PM (TTM) | 11.06% | ||
| GM | 30.02% | ||
| FCFM | 2.68% |
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
ROICexc(3y)13.33%
ROICexc(5y)16.93%
ROICexgc(3y)13.36%
ROICexgc(5y)17.03%
ROCE(3y)15.15%
ROCE(5y)17.2%
ROICexcg growth 3Y11.8%
ROICexcg growth 5Y-12.49%
ROICexc growth 3Y11.98%
ROICexc growth 5Y-12.32%
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 10.01 | ||
| Debt/EBITDA | 0.91 | ||
| Cap/Depr | 99.17% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 16.54 | ||
| Cash Conversion | 24.7% | ||
| Profit Quality | 24.26% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 7.01 |
F-Score6
WACC8.97%
ROIC/WACC2.06
Cap/Depr(3y)140.73%
Cap/Depr(5y)342.39%
Cap/Sales(3y)2.61%
Cap/Sales(5y)6.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168%
EPS 3Y-17.89%
EPS 5Y-6.76%
EPS Q2Q%335.71%
EPS Next Y278.39%
EPS Next 2Y97.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.44%
Revenue growth 3Y12.29%
Revenue growth 5Y14.66%
Sales Q2Q%33.4%
Revenue Next Year37.45%
Revenue Next 2Y19.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.34%
EBIT growth 3Y16.56%
EBIT growth 5Y7.53%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.74%
FCF growth 3YN/A
FCF growth 5Y22%
OCF growth 1Y210.27%
OCF growth 3YN/A
OCF growth 5Y13.23%